# Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine

> **NCT06316362** · PHASE2 · COMPLETED · sponsor: **Alexandria University** · enrollment: 40 (actual)

## Conditions studied

- Acute Poisoning

## Interventions

- **DRUG:** SMOF lipid 20%
- **OTHER:** Standard treatment for carbamazepine toxicity

## Key facts

- **NCT ID:** NCT06316362
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06316362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06316362, "Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06316362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*